What kind of company is BELVIQ?

IntroductionBelviq is a brand name for lorcaserin, a prescription weight-loss drug manufactured by Eisai Inc. The medication is only available on prescription from a healthcare professional and is intended to aid in weight management for obese or overweight adults.

Approval and market withdrawalBelviq was approved for the US market in 2012 by the US Food and Drug Administration (FDA) as an adjunct to diet and exercise for weight management. However, the medication was later withdrawn from the market in February 2020, following a safety clinical trial that showed an increased occurrence of cancer in individuals taking the medication.

How it worksBelviq works by targeting receptors in the brain that regulate appetite and energy levels. It promotes feelings of fullness or satiety, leading to a decrease in the amount of food consumed. The medication is intended to be used alongside a reduced-calorie diet and increased physical activity.

Side effectsSome of the common side effects associated with Belviq include headache, dizziness, fatigue, nausea, dry mouth, and constipation. Serious side effects may include low blood sugar, serotonin syndrome, and mental health problems such as depression, anxiety, or suicidal thoughts.

ConclusionDespite being withdrawn from the market, Belviq has helped many individuals manage their weight and improve their health. It is important to seek medical advice before starting any weight-loss medication as they may not be suitable for everyone.

Social media links